Sanofi-Aventis   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Leiden Netherlands (1991)

Organization Overview

First Clinical Trial
1995
NCT00378417
First Marketed Drug
1991
isoprenaline
First NDA Approval
1991
enoxacin (penetrex)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bioverativ - a sanofi company | Bioverativ, a Sanofi company | Clinical Science & Operation - sanofi-aventis | MCM Vaccines B.V. | Pasteur Merieux Connaught | Principia Biopharma, a Sanofi Company | SANOFI AVENTIS | sanofi-aventis administrative office | Sanofi-aventis administrative office Argentina | Sanofi-aventis administrative office Brazil | Sanofi-aventis administrative office France | Sanofi-aventis administrative office Gulf | sanofi-aventis Hungary | Sanofi-aventis, Hungary | sanofi-aventis Japan | Sanofi Aventis K. K. | Sanofi Aventis K.K. | sanofi-aventis, Sweden | Sanofi-aventis Turkey | Sanofi-aventis, Turkey | SANOFI AVENTIS US | SANOFI-AVENTIS US | sanofi-avents | Sanofi Pasteur | Sanofi Pasteur, a Sanofi Company | Sanofi Pasteur Asia Pacific | Sanofi Pasteur China | sanofi pasteur Inc | Sanofi pasteur Inc. | Sanofi Pasteur Inc. | Sanofi Pasteur, Inc | Sanofi Pasteur, Inc. | Sanofi Pasteur India Pvt Ltd | Sanofi Pasteur K.K | Sanofi Pasteur Ltd. | Sanofi Pasteur MSD | Sanofi Pasteur Philippines, Inc. | Sanofi Pasteur Russia | Sanofi Pasteur SA | Sanofi Pasteur SA. | Sanofi Pasteur Singapore | Sanofi Pasteur South Korea | SANOFI US SERVICES | SPMSD